major cryptocurrencies Knowledge

OPEC continues to lower its global oil demand forecast. According to Xinhua News Agency, the Organization of Petroleum Exporting Countries (OPEC) released its monthly oil market report on the 11th, lowering its global oil demand forecast for 2024 and 2025. This is the fifth time that OPEC has lowered its global oil demand forecast for this year and next since August this year.The first phase of the East Middle Route of South-to-North Water Diversion Project has transferred more than 76.7 billion cubic meters of water. The the State Council Information Office held a press conference at 10: 00 this morning. The relevant person in charge of the Ministry of Water Resources announced that the first phase of the East Middle Route of South-to-North Water Diversion Project has transferred more than 76.7 billion cubic meters of water since the tenth anniversary of the full water supply. The guarantee rate of urban living and industrial water supply along the line has been significantly improved. The water supply area of the project has been continuously extended, benefiting 185 million people in 45 large and medium-sized cities. The level of saving and intensive utilization of water resources in the receiving area has been comprehensively improved, and the overall level of water use efficiency is in the forefront of the country.Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.

Ping An Securities: The gold price center is expected to increase in 2025. Ping An Securities released the 2025 annual strategy report of nonferrous metals and new materials industry, saying that nonferrous metals have entered a stage of high fluctuation in 2024, and the main pricing lines and core variables have changed to varying degrees. 2025 is still a year in which the core contradictions of various varieties continue to ferment, and the monetary attributes of precious metals represented by gold are expected to continue to be prominent. It is expected that the gold price center will still improve throughout the year, and it is recommended to pay attention to Shandong gold and Zhongjin gold; The long-term resource bottleneck of industrial metal copper has bottomed out, and the demand elasticity driven by internal and external policies is expected to be gradually released. It is suggested to pay attention to Zijin Mining and Luoyang Molybdenum Industry; The supply and demand pattern of electrolytic aluminum continues to improve, and the demand side maintains a high growth rate under the shrinking supply elasticity, and the long-term center of aluminum price is expected to further rise. It is recommended to pay attention to Tianshan Aluminum, China Aluminum, Shenhuo and Yunnan Aluminum. Tin resources are in short supply or accelerated transmission, and the gap between supply and demand is further enlarged. It is suggested to pay attention to tin industry shares; At the bottom of the energy metal industry, it is confirmed that enterprises with lower valuation level may enjoy greater flexibility under the marginal improvement of fundamentals. It is recommended to pay attention to enterprises with significant integration advantages, and it is recommended to pay attention to China Mining Resources, Tianqi Lithium Industry and Huayou Cobalt Industry.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.

Chuanrun helps Goldwind Technology roll off the production line of a new generation of deep-sea 22MW offshore wind turbines. According to Sichuan Chuanrun Co., Ltd., recently, Goldwind Technology successfully rolled off the production line of a new generation of deep-sea 22MW offshore wind turbines in Shantou manufacturing base, setting a new record for Guangdong's largest single-unit capacity offshore wind turbines. As a key technical partner, Chuanrun provided a complete set of cooling system and lubrication system for the unit, which demonstrated the company's technical strength and innovation ability in the field of wind power.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.